Javascript must be enabled to continue!
Immunohistochemical comparison between anaplastic seminoma and typical seminoma
View through CrossRef
In order to study the possible biological differences between anaplastic and typical seminoma, the following factors were studied in 11 cases of anaplastic seminoma and 15 cases of typical seminoma: mitotic activity, proliferating cell nuclear antigen (PCNA) expression, immunohistochemical analyses for cytokeratin, vimentin, placental alkaline phosphatase (PLAP), β‐human chorionic gonadotropin (β‐hCG), a‐fetoprotein (AFP) and c‐myc oncoprotein. Anaplastic seminoma was classified according to Mostofi's criteria, which is primarily based on the mitotic activity of the tumor. Mitotic activity was evaluated by both mitotic count and rate. Statistically significant correlations were observed between mitotic count and mitotic rate (R= 0.891), and between the mitotic count and PCNA labeling index (R= 0.792), in both typical and anaplastic seminomas. Immunostaining patterns for cytokeratin, vimentin, PLAP, β‐hCG, AFP and c‐myc oncoprotein were not significantly different between typical and anaplastic seminoma. The present data indicated that no apparent clinicopathologic and immunohistochemical parameters discerning anaplastic seminoma from typical seminoma were present, when identifying anaplastic seminoma on the basis of high mitotic count. Anaplastic seminoma may therefore simply represent seminoma with high proliferative activity.
Title: Immunohistochemical comparison between anaplastic seminoma and typical seminoma
Description:
In order to study the possible biological differences between anaplastic and typical seminoma, the following factors were studied in 11 cases of anaplastic seminoma and 15 cases of typical seminoma: mitotic activity, proliferating cell nuclear antigen (PCNA) expression, immunohistochemical analyses for cytokeratin, vimentin, placental alkaline phosphatase (PLAP), β‐human chorionic gonadotropin (β‐hCG), a‐fetoprotein (AFP) and c‐myc oncoprotein.
Anaplastic seminoma was classified according to Mostofi's criteria, which is primarily based on the mitotic activity of the tumor.
Mitotic activity was evaluated by both mitotic count and rate.
Statistically significant correlations were observed between mitotic count and mitotic rate (R= 0.
891), and between the mitotic count and PCNA labeling index (R= 0.
792), in both typical and anaplastic seminomas.
Immunostaining patterns for cytokeratin, vimentin, PLAP, β‐hCG, AFP and c‐myc oncoprotein were not significantly different between typical and anaplastic seminoma.
The present data indicated that no apparent clinicopathologic and immunohistochemical parameters discerning anaplastic seminoma from typical seminoma were present, when identifying anaplastic seminoma on the basis of high mitotic count.
Anaplastic seminoma may therefore simply represent seminoma with high proliferative activity.
Related Results
Anaplastic testicular seminoma presenting as a hydrocele, in a 36-year-old patient with a family history of anaplastic seminoma
Anaplastic testicular seminoma presenting as a hydrocele, in a 36-year-old patient with a family history of anaplastic seminoma
Testicular cancer is the solid tumor with the greatest incidence in men between 15 and 44 years old. Its main histological type is germ cell tumor, that is divided into seminomatou...
Detection of Alpha‐Fetoprotein mRNA in Seminoma
Detection of Alpha‐Fetoprotein mRNA in Seminoma
ABSTRACT: The classic testicular tumor marker alpha‐fetoprotein (AFP) is associated with nonseminomatous germ cell tumors, including embryonal carcinoma, yolk sac tumor, and terat...
IMMUNOHISTOCHEMICAL ANALYSIS OF PATIENTS WITH LUMINAL B BREAST CANCER: PATHOLOGICAL PARAMETERS AND THERAPEUTIC STRATEGIES
IMMUNOHISTOCHEMICAL ANALYSIS OF PATIENTS WITH LUMINAL B BREAST CANCER: PATHOLOGICAL PARAMETERS AND THERAPEUTIC STRATEGIES
Introduction: Breast cancer (BC) is one of the leading malignancies among women, exhibiting significant molecular and histological heterogeneity. The Luminal B subtype is a hormone...
New Guidelines for Clinical Stage I Testicular Seminoma?
New Guidelines for Clinical Stage I Testicular Seminoma?
Clinical stage I (CS I) seminoma has been the subject of various studies aimed at finding the ideal treatment. Due to its high radiosensitivity, radiotherapy has been the standard ...
Single‐cell mRNA sequencing of giant panda (Ailuropoda melanoleuca) seminoma reveals the cellular and molecular characteristics of tumour cells
Single‐cell mRNA sequencing of giant panda (Ailuropoda melanoleuca) seminoma reveals the cellular and molecular characteristics of tumour cells
AbstractTesticular tumours are zoonoses that can occur in not only human, but other animals, include giant pandas. A middle‐aged male giant panda named Fufu was diagnosed with a te...
Primary seminoma of the prostate
Primary seminoma of the prostate
AbstractA 54‐year‐old gentleman was suspected of having sarcoma of the prostate because of his low serum prostate‐specific antigen level (1.9 ng/mL) and an enlarged heterogeneous m...
Anaplastic thyroid cancer with life-threatening symptoms in an older female - a case report
Anaplastic thyroid cancer with life-threatening symptoms in an older female - a case report
Introduction: Anaplastic thyroid cancer, also called undifferentiated, is an uncommon and highly aggressive thyroid neoplasm that usually occurs in patients above 60 years of age (...
Anaplastic Thyroid Cancer: Recent Trend Toward Improved Survival
Anaplastic Thyroid Cancer: Recent Trend Toward Improved Survival
Abstract
Background: Anaplastic thyroid carcinoma is a rare malignant tumor of the thyroid. In this study, we summarize the survival changes of Anaplastic thyroid carcinoma...

